Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M T Candel

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
British Journal of Cancer|June 9, 1999
A randomized phase II trial of 5-fluorouracil, with or without human interferon-beta, for advanced colorectal cancerA Villar-Grimalt, M T Candel, B Massuti, et al.
Medicina Clinica|February 29, 1992
[Size of breast cancer at the time of initial diagnosis]A Villar, M T Candel, F Delgado, et al.
Tumori|April 30, 1994
Phase II study with iododoxorubicin in measurable advanced colorectal adenocarcinoma. Effective rescue using weekly high-dose 5-fluorouracil (WFU). Spanish Cooperative Group for Gastrointestinal Tumor Therapy (TTD), Work Group of SEOM (Spanish Medical Oncology Society)A Villar-Grimalt, E Aranda, B Massutí, et al.
American Journal of Clinical Oncology|October 1, 1991
120-hour 5-fluorouracil (5-FU) continuous infusion (CI) plus BCNU in advanced colorectal cancerA Villar-Grimalt, M T Candel, F Delgado, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 11, 2003
Doxorubicin in combination with fluorouracil and cyclophosphamide (i.v. FAC regimen, day 1, 21) versus methotrexate in combination with fluorouracil and cyclophosphamide (i.v. CMF regimen, day 1, 21) as adjuvant chemotherapy for operable breast cancer: a study by the GEICAM groupM Martin, A Villar, A Sole-Calvo, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
British Journal of Cancer|June 9, 1999
A randomized phase II trial of 5-fluorouracil, with or without human interferon-beta, for advanced colorectal cancerA Villar-Grimalt, M T Candel, B Massuti, et al.
Medicina Clinica|February 29, 1992
[Size of breast cancer at the time of initial diagnosis]A Villar, M T Candel, F Delgado, et al.
Tumori|April 30, 1994
Phase II study with iododoxorubicin in measurable advanced colorectal adenocarcinoma. Effective rescue using weekly high-dose 5-fluorouracil (WFU). Spanish Cooperative Group for Gastrointestinal Tumor Therapy (TTD), Work Group of SEOM (Spanish Medical Oncology Society)A Villar-Grimalt, E Aranda, B Massutí, et al.
American Journal of Clinical Oncology|October 1, 1991
120-hour 5-fluorouracil (5-FU) continuous infusion (CI) plus BCNU in advanced colorectal cancerA Villar-Grimalt, M T Candel, F Delgado, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 11, 2003
Doxorubicin in combination with fluorouracil and cyclophosphamide (i.v. FAC regimen, day 1, 21) versus methotrexate in combination with fluorouracil and cyclophosphamide (i.v. CMF regimen, day 1, 21) as adjuvant chemotherapy for operable breast cancer: a study by the GEICAM groupM Martin, A Villar, A Sole-Calvo, et al.
Pageof 1